Neurocrine Biosciences Inc vs Rent the Runway Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Rent the Runway Inc trades at $3.11 (market cap $104.26M). The key difference: Neurocrine Biosciences Inc is far larger — about 166.9× Rent the Runway Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | RENT | |
|---|---|---|
Market Cap | $17.40B | $104.26M |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $9.39 |
52-Week Low | $123.10 | $3.09 |
Enterprise Value | $16.49B | $264.36M |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →